Eli Lilly and Company

Other

David Kent Herron

Michael Robert Wiley

Gerald Floyd Smith

John Joseph Masters

Ying Kwong Yee

David Mendel

Theodore Goodson, Jr

Jeffry Bernard Franciskovich

Anne Louise Tebbe

Valentine Joseph Klimkowski

Jason Scott Sawyer

Douglas Wade Beight

Steven E Hall

James Howard Wikel

Robert T Shuman

Jennifer Marie Tinsley

Trelia Joyce Craft

Leonard Crayton Weir

Guy Milot

Jeffrey Alan Kyle

Sajan Joseph

Angela Lynn Marquart

Marta Maria Pi&ntilde;eiro-N&uacute;&ntilde;ez

Andrew Michael Ratz

William H Lunn

Richard Waltz Harper

Leander Merritt

Philip Parker Waid

Nancy G Bollinger

Carl Penman Denny

Theodore Goodson, Junior

Marta Maria Pi&ntilde;eiro-Nu&ntilde;ez

Robin D Cooper

Celia A Whitesitt

Leland O Weigel

Marta Maria Pineiro-Nunez

Jared Harris Linebarger

Salvatore Donato Lepore

Theodore Goodson Jr

Jeffrey Bernard Franciskovich

Ankush Baburao Argade

Marta Maria Pinelro-Núnez

Guy Milet

Theodore Junior Goodson

Ankush B Rigel Pharmaceuticals Inc Argade

This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor. An example of a compound of formula (I) is (a). 

Aromatic ether derivatives useful as thrombin inhibitors

This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt of the compound) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor. 

Antithrombotic diamides

This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor (I). 

Antithrombotic ethers

This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor.

Antithrombotic aromatic ethers

This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor. 

Substituted heterocyclic carboxamides with antithrombotic activity

This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Substituted carboxamides

This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Substituted heterocyclic amides

Aromatic amides

Antithrombotic amides

This application relates to heteroaromatic amides (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Heteroroaromatic amides as inhibitor of factor Xa

This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Antithrombotic agents

Growing community of inventors

Indianapolis, IN, United States of America

David Kent Herron